CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing taspoglutide with pioglitazone in patients with type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED